Publications by authors named "Lisa Kierstead"

Claim this Profile
H
Harmonization of Vaccine Ligand Binding Assays Validation.
Francis Dessy, Ivo Sonderegger, Leslie Wagner, Alessandra Buoninfante, Meenu Wadhwa, Lisa Kierstead

Bioanalysis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
Marie E Bonhomme, Cyrille J Bonhomme, Lisa Strelow, Atul Chaudhari, Adrienne Howlett, Lisa Kierstead

PLoS One· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recommendations on ELISpot assay validation by the GCC.
Rafiq Islam, Jennifer Vance, Martin Poirier, Jennifer Zimmer, Ardeshir Khadang, Lisa Kierstead

Bioanalysis· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( - Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene & Cell Therapy and Vaccine Assays).
Bart Corsaro, Tong-Yuan Yang, Rocio Murphy, Ivo Sonderegger, Andrew Exley, Lisa Kierstead

Bioanalysis· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy Adults.
Ouzama Nicholson, Fay DiCandilo, James Kublin, Xiao Sun, Erin Quirk, Lisa Kierstead

AIDS Res Hum Retroviruses· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality.
Natalie A Hutnick, Diane G Carnathan, Sheri A Dubey, Kara S Cox, Lisa Kierstead

PLoS One· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials.
T Christopher Mast, Lisa Kierstead, Swati B Gupta, Alexander A Nikas, Esper G Kallas

Vaccine· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative cell-mediated immunogenicity of DNA/DNA, DNA/adenovirus type 5 (Ad5), or Ad5/Ad5 HIV-1 clade B gag vaccine prime-boost regimens.
David M Asmuth, Elizabeth L Brown, Mark J DiNubile, Xiao Sun, Carlos del Rio, Lisa S Kierstead

J Infect Dis· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells.
Natalie A Hutnick, Diane G Carnathan, Sheri A Dubey, George Makedonas, Kara S Cox, Lisa Kierstead

Nat Med· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.
Clayton D Harro, Michael N Robertson, Michelle A Lally, Lori D O'Neill, Srilatha Edupuganti, Lisa S Kierstead

AIDS Res Hum Retroviruses· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis.
M Juliana McElrath, Stephen C De Rosa, Zoe Moodie, Sheri Dubey, Lisa Kierstead

Lancet· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a replication-incompetent adenovirus type 5 HIV-1 clade B gag/pol/nef vaccine in healthy adults.
Frances H Priddy, Deborah Brown, James Kublin, Kathleen Monahan, David P Wright, Lisa S Kierstead

Clin Infect Dis· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay.
Sheri Dubey, James Clair, Tong-Ming Fu, Liming Guan, Romnie Long, Lisa Kierstead

J Acquir Immune Defic Syndr· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC.
Lisa S Kierstead, Sheri Dubey, Barbara Meyer, Timothy W Tobery, Robin Mogg

AIDS Res Hum Retroviruses· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates.
Stefania Capone, Immacolata Zampaglione, Alessandra Vitelli, Monica Pezzanera, Lisa Kierstead

J Immunol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma.
Tomohide Tatsumi, Lisa S Kierstead, Elena Ranieri, Loreto Gesualdo, Francesco P Schena

Clin Cancer Res· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Memory T cells and vaccines.
Mark T Esser, Rocio D Marchese, Lisa S Kierstead, Lynda G Tussey, Fubao Wang

Vaccine· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma.
Tomohide Tatsumi, Lisa S Kierstead, Elena Ranieri, Loreto Gesualdo, Francesco P Schena

J Exp Med· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis